Результаты поиска - K. B. Mirzaev

Change of opinion on the use of hydroxychloroquine for COVID-19 treatment and prevention по K. B. Mirzaev, D. A. Sychev

Connect to this object online.

Current and future use of remdesivir in patients with COVID-19 по V. M. Tsvetov, K. B. Mirzaev, D. A. Sychev

Connect to this object online.

Methylprednisolone in acute respiratory distress-syndrome in COVID-19: rationales for use, optimal dosage regimens, combined use with tocilizumab по K. B. Mirzaev, Yu. Yu. Kiselev, D. A. Sychev

Connect to this object online.

EVALUATION OF PLATELET AGGREGATION IN CLINICAL PRACTICE по K. B. Mirzaev, D. A. Andreev, D. A. Sychev

Connect to this object online.

EVALUATION OF PLATELET AGGREGATION IN CLINICAL PRACTICE по K. B. Mirzaev, D. A. Andreev, D. A. Sychev

Connect to this object online.

Could canakinumab be used for COVID-19? по V. A. Otdelenov, K. B. Mirzaev, D. A. Sychev

Connect to this object online.

Possibility for the use of bromhexine to prevent infection with SARS-CoV-2 по K. A. Zagorodnikova, K. B. Mirzaev, D. A. Sychev

Connect to this object online.

Possibility to use direct oral anticoagulants to prevent thromboembolic events in patients with COVID-19 по V. A. Otdelenov, K. B. Mirzaev, D. A. Sychev

Connect to this object online.

Dexamethasone use in patients with COVID-19 по V. A. Otdelenov, K. B. Mirzaev, D. A. Sychev

Connect to this object online.

Is it possible to use riamilovir to prevent infection and treat COVID-19? по V. M. Tsvetov, K. B. Mirzaev, D. A. Sychev

Connect to this object online.

Can inhalations of hyaluronidase be used in acute respiratory distress-syndrome in patients with COVID-19? по Yu. Yu. Kiselev, K. B. Mirzaev, D. A. Sychev

Connect to this object online.

Current and future use of dipyridamole in patients with COVID-19 по I. S. Burashnikova, V. M. Tsvetov, K. B. Mirzaev, D. A. Sychev

Connect to this object online.

Multi-Ethnic Analysis of Cardiac Pharmacogenetic Markers of Cytochrome P450 and Membrane Transporters Genes in the Russian Population по K. B. Mirzaev, D. S. Fedorinov, D. V. Ivashchenko, D. A. Sychev

Connect to this object online.

Current and future use of aminodihydrophthalazindione sodium in patients with COVID-19, including for «cytokine storm» therapy по V. M. Tsvetov, Yu. Yu. Kiselev, K. B. Mirzaev, D. A. Sychev

Connect to this object online.

What are the indications for combined use of hydroxychloroquine and lopinavir/ritonavir, and how should treatment safety monitoring be performed? по Yu. Yu. Kiselev, V. M. Tsvetov, K. B. Mirzaev, D. A. Sychev

Connect to this object online.

THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE по K. B. Mirzaev, D. A. Sychev, D. A. Andreev, A. B. Prokofiev

Connect to this object online.

THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE по K. B. Mirzaev, D. A. Sychev, D. A. Andreev, A. B. Prokofiev

Connect to this object online.

Monitoring of safety using favipiravir: risk management of adverse drug reactions in clinical practice по Yu. Yu. Kiselev, A. V. Matveev, K. B. Mirzaev, D. A. Sychev

Connect to this object online.

The CES1 Gene rs2244613 Minor Allele Impact on the Safety Profile of Dabigatran Etexilate: Meta-Analysis по S. P. Abdullaev, K. B. Mirzaev, P. O. Bochkov, I. N. Sychev, D. A. Sychev

Connect to this object online.

Rationale for use mefloquine for COVID-19 treatment по V. A. Otdelenov, K. B. Mirzaev, A. V. Dmitriev, V. V. Poroikov, D. A. Sychev

Connect to this object online.